Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aridis, Bridge, Firstwave, Fujifilm, Kezar, Laurent, Mesoblast, Neoimmunetech, Otonomy, Sirnaomics, Tenax, Vigeo, Zelira.

Biopharmas raising money in public or private financings, including: Anika, Scynexis.

New hires and promotions in the biopharma industry, including: Aravive, Azurrx, Hemostemix, PDS.

Med-tech firms raising money in public or private financings, including: Health Catalyst.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Acceleron, Aeglea, Aeterna Zentaris, Algernon, Bellerophon, BMS, Nicox, Polaryx and Roche.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Akers, Astrazeneca, Avacta, Aytu, CSL Behring, Danaher, EOC, Epivax, Flow, GSK, Hitgen, Immutep, Lamellar, Medicinova, Metriopharm, Mitsubishi Tanabe, Nascentbiotech, Novacyt, Organovo, Ossianix, Oxford Biomedica, Pacific Biosciences, Pharmacyte, Polarityte, Premas, Quell, Recce, Recordati, Regeneron, Revive, SAB, Suda, Tarveda, T-Cure, Zai Lab.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Addex, Aivita, Catalyst, Neuclone, Novotech, Obi, Trillium, Viriom.

Biopharmas raising money in public or private financings, including: Chiasma, Idera, Keros, Mersana, Q Biomed, Santhera, Zentalis.

New hires and promotions in the biopharma industry, including: Asklepios, Glycomimetics, Morphic.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Ansun, Apeiron, Cytodyn, Eusa, Hutchison China Meditech, I-Mab, Inflarx, Inovio, Kiniksa, Nanocarrier, Novan, Oncoceutics, Sato, Synairgen, Vanda, VBL.